China SXT Pharmaceuticals (SXTC) Raw Materials (2023 - 2025)

China SXT Pharmaceuticals' Raw Materials history runs 3 years deep, the most recent figure standing at $435799.0 for Q1 2025.

• In Q1 2025, Raw Materials rose 35.88% year-over-year to $435799.0; the TTM figure through Mar 2025 stood at $435799.0 (up 35.88% YoY), while the FY2025 annual figure was $435799.0, up 35.88% from the prior year.
• Raw Materials was $435799.0 for Q1 2025 at China SXT Pharmaceuticals, up from $320722.0 in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $435799.0 in Q1 2025 to a low of $243222.0 in Q1 2023.
• Historically, Raw Materials has averaged $333247.7 across 3 years, with a median of $320722.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Raw Materials jumped 31.86% in 2024, then surged 35.88% in 2025.
• A 3-year view of Raw Materials shows it stood at $243222.0 in 2023, then surged by 31.86% to $320722.0 in 2024, then soared by 35.88% to $435799.0 in 2025.
• The last three Raw Materials figures came in at $435799.0 (Q1 2025), $320722.0 (Q1 2024), and $243222.0 (Q1 2023), per Business Quant data.